Abstract: A bone replacement material having reinforcing elements and a modelable mass which is curable on contact with water or an aqueous liquid. as well as a process for producing a bone replacement material, to a further bone replacement material and to medical kits for treatment of bone defects.

Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.

Abstract: Provided is a drug delivery composition comprising at least one polymer and at least one active agent; wherein the active agent is present in crystalline form on at least one region of an outer surface of the composition and wherein active agent surface content is adjusted to provide a selected active agent release profile.

Abstract: Cosmetic compositions comprising water, at least one estolide ester compound of Formula (3) wherein n is from 1 to 10, preferably from 2 to 8, and R is selected from branched or linear C3-20-alkyl, and B) optionally at least one surfactant component B, C) optionally at least one thickener component C, D) optionally at least one hair conditioning component D, and E) optionally at least one further component E, different to A to D, can be used for improved hair treatment.

Abstract: Cosmetic agents for temporarily deforming keratinic fibers and methods for temporarily deforming keratinic fibers using the cosmetic agents are provided. In an embodiment, a cosmetic agent comprises: a) a cosmetic preparation comprising: a1) at least one copolymer comprising at least the following monomer units: (meth)acrylic acid; (meth)acrylic acid alkyl ester; and (meth)acrylic acid hydroxy alkyl ester; and a2) at least one copolymer comprising at least the following monomer units: styrene; and acrylic acid and/or methacrylic acid, wherein the proportion by weight of copolymers a1) and a2) in the total weight of the cosmetic preparation is about 10 to about 30% by weight.

Abstract: A hand sanitizing composition and a method of manufacture, wherein the composition includes a solvent from about 78% to about 96% by weight sufficient to operate as a carrier and solvent. The composition includes tetrasodium EDTA and/or Sodium Citrate from about 0.01% to about 1% by weight to operate as a buffer, stabilizer and chelating agent. The composition includes a humectant selected from the group of humectants consisting of: Cetyl Alcohol, Ceteryl Alcohol, and Steryl Alcohol from about 1.5% to about 5.5% by weight to emulsify, thicken and lubricate. The composition includes an emollient from about 0.1% to about 3.2% by weight and an antioxidant vitamin from about 0.01% to about 1% by weight. The composition includes a soothing agent in a therapeutically significant amount and a conditioner.

Abstract: Human lubricating gels, methods and kits for delivering a therapeutic agent to a target tissue site beneath the skin of a patient utilizing human lubricating gel are provided, the human lubricating gel being capable of adhering to the target tissue site and comprising one or more biodegradable formulations containing an effective amount of the therapeutic agent. In various embodiments, the human lubricating gel is sprayable and hardens after contacting the target tissue site.

Abstract: Compositions comprising from about 40 weight parts to about 1000 weight parts of a botanical nitrate source; from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; and from about 4 weight parts to about 100 weight parts of a nitrite salt. Use of the composition in methods of reducing triglycerides or reducing C-reactive protein levels are also provided.

Abstract: Aqueous emulsions of organopolysiloxanes functionalized with a limited amount of aminoalkyl-functional end groups and silicone resins are storage stable, yet capable of adequate crosslinking upon application to substances to be hydrophobicized.